Article
ROR2 regulates cellular plasticity in pancreatic neoplasia and adenocarcinoma
medRxiv · 2024 · Benitz, S.; Steep, A.; Nasser, M.; Preall, J.; Mahajan, U. M.; McQuithey, H.; Loveless, I.; Davis, E. T.; Wen, H.-J.; Long, D. W.; Metzler, T.; Zwernik, S.; Louw, M.; Rempinski, D.; Salas-Escabillas, D.; Brender, S.; Song, L.; Huang, L.; Zhang, Z.; Steele, N. G.; Regel, I.; Bednar, F.; Crawford, H. C.
Key facts
| Title | ROR2 regulates cellular plasticity in pancreatic neoplasia and adenocarcinoma |
|---|---|
| First author | Benitz, S.; Steep, A.; Nasser, M.; Preall, J.; Mahajan, U. M.; McQuithey, H.; Loveless, I.; Davis, E. T.; Wen, H.-J.; Long, D. W.; Metzler, T.; Zwernik, S.; Louw, M.; Rempinski, D.; Salas-Escabillas, D.; Brender, S.; Song, L.; Huang, L.; Zhang, Z.; Steele, N. G.; Regel, I.; Bednar, F.; Crawford, H. C. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2023.12.13.571566 |
| Devices mentioned | 018354 |
| Product codes mentioned | MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1